[0:01]You are most welcome to this talk. Now, this video is about the possible relationship between COVID mRNA vaccines and the development of cancers that affect the hematopoietic system, the blood forming system, things like the bone marrow that can lead to lymphomas and leukemias. We'll be looking at a case study and we'll also be looking at the plausible mechanisms. So, this paper I'm going to discuss identifies quite a lot of plausible mechanisms whereby the mRNA lipid nanoparticle vaccines could using sound principles of biochemistry, physiology, and anatomy, lead to the development of cancers. Now, this is taken from this paper here, uh peer-reviewed published in Oncotarget, exploring the potential link between mRNA COVID-19 vaccinations and cancer. So that is what it's going to be based on. Very readable paper. Uh do check it out for yourself. It does get a bit technical and it talks about the case study, but the introduction of the first part is very readable. And also, uh probably won't cover this in this video, but there's also been horrendous problems that the author's going to tell us about, personal message from the author later on by the way, or one of the authors. Um he's actually published something else here on um censorship in science, for we might be looking at that. Uh in the few not not in this video, probably in the next one. And uh the great difficulty in getting things published if they don't fit the mainstream narrative. Anyway, let's get on with the detail of this paper, and as you'll see it's a very scientific, rational piece of work. Um, so that's what we're investigating, hematopoietic, blood forming, poiesis the formation of blood, hem obviously blood. And this is the article on censorship in science, the difficulty in getting this information out there. This has been coming for a long, long time. I started talking to this author, oh probably well over a year ago now, and this is just something coming out now. So, um it's been difficult, but that's that's another story. Let's deal with the content, then we'll deal with the difficulty in the process. Um, but he does say only relentless determination gets uh dissenting data published in peer-reviewed journals, and by dissenting I I would say analytical because this is an analytical article. The article is uh is scientific. Um and and as indeed it's been peer-reviewed as such and is written by significant scientists. Um now, case study, this is there's a case study here, healthy, young, athletic woman who, very athletic actually, um developed acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL), um shortly after the COVID vaccine. So to get one is indeed unfortunate. To get two at the same time, um well I'm not a specialist in this, I'm not a hematologist by any means, uh but I've never looked after a patient who's had both at the same time as far as I can remember. Um if you're in the field, do let me know, but I think it's very unusual to develop both at the same time. But this was the both following her second dose of the Pfizer/BioNTech COVID-19 vaccine (Comirnaty®), (July 2021). Um, Now, oh, that's right. Um, going going on from this, um she had uh I'm not going to go through the details of the story, but basically, let's say she suffered a lot for a long period of time. And then in 2025, she had what you call she had some preparatory drugs and what you call total body radiation. So her body was radiated to kill all the bone marrow and, of course, when you kill all the bone marrow you kill all the malignant bone marrow. Very dangerous thing to do, obviously. I have seen patients with this and we have to be remarkably careful that they don't get infections. Uh and then she was given a a bone marrow transplant from from an unknown donor. And at the moment, she is doing uh quite well. But that's a pretty invasive treatment and she suffered for a long time. So, um she had uh cell transplant from an unrelated donor. Now, this article is part of an expanding body of literature documenting similar occurrences after modRNA vaccinations according to this paper that we're discussing. And I agree, I've been seeing these around for some time now. Now, the authors do point out that there's 30 papers describe malignancies developing in close temporal correlation with Moderna RNA, sorry, uh modified, uh Pfizer and Moderna. uh modified ribonucleic acid COVID-19 vaccinations. And sometimes that temporal correlation, um in other words that the cancer occurs just after the the vaccine, uh sometimes just a few days. And of those 30 papers, 28 focused on uh hemo-lymphoproliferative disorders, in other words, leukemias and lymphomas basically. And and in four cases, uh showed onset at the inoculation site. So the first sign of the disease was where the vaccination had been given, and another three were from the uh the lymph nodes. So like if you were given the injection in the deltoid there, that would be drained to these lymph nodes here. Three cases of the hematopoietic malignancies presented in those uh lymph nodes. Four at the site. Coincidence? You tell me. I would have thought not. Yep. Uh so yeah, so that's seven uh close temporal correlations. Now, in Japan, leukemia, breast cancer, pancreatic, and lip/oral/pharyngeal cancers increased significantly in 2022. Now this is published in this paper here and of course um we did review this at the time. And uh let me show you this paper, uh from Japan. Here it is here. Uh we see increased increased age adjusted cancer mortality after the third mRNA-Lipid nanoparticle vaccine dose during the COVID-19 pandemic in Japan. Oh, it's been retracted. Oh, that article has been retracted. That retraction may not surprise you. There's been a lot of retractions of various papers. When I looked at it at the time, I thought it was a good article, I must say. Uh but here's the uh notification of the retraction. So it appeared to be showing uh increased cancers in Japan, uh at a population level.
[7:15]But it was retracted. So, technically, we can take no count of it because it's a retracted paper. So, as the authors of this paper that we're currently looking at, uh the paper that we're currently looking at, um with uh Dr. Polykretis, um in that article, they do notice that there's a critical literature gap.
[7:41]Indeed, critical literature gap, absence of population studies verifying cancer incidence by vaccination status in order to estimate the true cancer incidence or mortality increases following COVID-19 vaccination. So, we are desperately short of this literature. Now, we know that the British government, for example, uh does have the uh vaccination records for people that have given COVID vaccinations. We know they have record of the um the deaths. The excess deaths in 2021, 2022, 2023. Um and we know the number of people vaccinated, and we know the um the excess deaths. Lots of people were vaccinated, and there was a huge amount of excess deaths. The government won't release the data that shows which of those excess were were vaccinated. Now, they have released that information to the pharmaceutical companies, so they know, but we don't know. So, papers are being retracted, data is being officially withheld by governments. Make what you want of that.
[8:49]But the result is that we are very short of literature. Now, technically, of course, the vaccines are uh prodrugs, so they they're not actually drugs themselves, they're prodrugs, they can be for the drug, drug, and the gene therapies encased in the lipid nanoparticles rather than natural naked mRNA. So, some RNA will get into the circulation from time to time, but it's naked and therefore it's disposed off probably in seconds, certainly within minutes by the immune system. But if it's in these lipid nanoparticles, it can't get to it, so it's protected. The genetic preparations are protected. Um, emerging evidence suggests that biodistribution and persistence of modRNA, facilitated by lipid nanoparticles, can affect various tissues and organs. And we now know, we now know that these lipid nanoparticles are systemically distributed and we know that an awful lot of them go to the bone marrow where the cells can become malignant that cause leukemia and lymphoma. It all starts to make potential sense, but much more evidence to come as we go through. Um, so it can go everywhere. It can go to your ears, your toes, your nose, your eyes, your heart, your lungs, your brain, everywhere. Your liver, your kidneys, your intestines, including the bone marrow and other blood forming organs, for sure. So, we know these lipid nanoparticles go to the blood forming organs where the blood forming cells are. And if these cells become damaged, they mutated, damaged, they can become leukemic or lymphomic cells. I like the turn of phrase the author's used, unfettered access through most tissues and organs. They can just go where they want. The lipid nanoparticles means that the lipid nanoparticles themselves and the modified ribonucleic acid is well and truly off the leash. It can go anywhere. This is why we need a moratorium on these vaccines, genetic preparations for now until we know a lot more. Um, notably, modified RNA vaccines exhibit a particular affinity for the bone marrow, so particularly likelihood that they will actually go to the uh to the bone marrow, which of course is is particularly concerning. Potentially influencing the immune system at multiple levels and, triggering both autoimmune disorders and neoplastic processes. So, if you affect the um the bone marrow, you affect the immune cells. Then, first of all, you can reduce the amount of immune cells, and that means that the immune system is no longer checking all the cells in the body all the time to make sure none are going malignant because what happens is, most of us, most of us, most days, get cancer. But, thankfully, at a very early stage, the immune system eradicates it. So, that immune surveillance can be reduced. But as well as that if you cause malignant changes in the cells, then instead of getting normal white blood cells, you'll get cancerous, malignant white blood cells which are no good at all. So the irony is that in leukemia, le means white, the blood is full of white cells, but they're malignant white cells, so the patients can die of infection because the cells are no good, they're malignant, they no longer do their job. So it can work both ways, once the bone marrow is uh is affected. I'm afraid it does make a lot of sense. Um, triggering both autoimmune disorders and neoplastic processes. So it can cause autoimmunity where the body beats up on its own tissues and neo new plastic tissue, new in other words, cancer type tissues, issues. Neoplastic processes, new tissues are made. If it's in the blood then the new tissue is the white blood cells and the the lymphoma cells that can go all over and, of course, in solid tumors it you can feel the the new tissue. By integrating clinical observations and current research, that's good, that's what they do in this paper, we aim to provide valuable insights into the potential carcinogenic outcomes associated with modified RNA vaccination. So, quite a lot of data there already, but there are real mechanisms here. Let's just quickly run through some of the mechanisms. Um, now, some of them are straightforward, some of them are more complicated biochemistry. I'll just give them a a brief explanation, but if you haven't got time for the rest of this video, suffice it to say there are plausible pathogenic mechanisms of cancer causation in the bone marrow as a result of mRNA lipid nanoparticle vaccines. So, cancer potential cancer causing mechanisms, oncogenesis, carcinogenesis. We know that spike protein is toxic. And vaccine induced spike protein lasts for longer than the natural spike. So the natural spike protein will be recognized and dealt with by the immune system quite quickly. The synthetic spike protein hangs around for much, much longer and indeed for very long periods of time indeed in some cases we've looked at, from memory I think one case for 700 days, for memory. Um, a double proline that confers greatest stability, so so the there's greatest stability in the spike. Not going to go into the biochemical details in that. Don't fully understand it, but the biochemists assures it's true. We can believe them. And what we already we also know the the synthetic pseudo uridine so the uridine uh base is synthetic contained in the modified RNA. They didn't use the normal uridine base, they use a synthetic one, and uh that's shown mitochondrial toxicity amongst other things and and a resistance to being broken down by the immune system. It has been demonstrated that this modification can increase the likelihood of plus one ribosomal frame shifting during translation. Ribosome, spelling this briefly, some of you know all a lot of you know already, but but basically when when when the DNA message or the RNA message is being trans- So when the RNA message is being translated into proteins, three um three bases in the RNA codes for one amino acid. But if you shift those along one, then instead of having amino acids one, two and three, uh the ribosome will will be reading amino acids two, three and four. And then five, six and seven. So, it'll all be out of sync. It'll be shifted forward one. And that means you get a completely different set of amino acids. Completely different set of peptides and proteins. And who knows what what that could mean, not the protein that was intended at all, but all these other random ones, some of which could potentially be uh cancer causing. Anyway, this frame shifting results in the production of multiple peptide products with unexplored effects. What the heck are these things doing? Don't know. Don't really want to know but we might have to find out unfortunately because they may be causing disease. This obviously poses serious safety concerns as only a single antigen was supposed to be encoded by the modified RNA, not many undefined peptides with unknown antigenic and autoimmune potential.
[16:13]Amyloid proteins could be one of them, which we've looked at in other contexts. The lipid nanoparticles themselves exhibit intrinsic cytotoxicity. So, even if the lipid nanoparticles are empty, which they're not, but even if they were, um, they're still toxic to cells. The lipid nanoparticles themselves are toxic, as well as their cargo.
[16:38]Um, presence of lipid nanoparticle encapsulated. Ah, the DNA contamination, DNA contamination originating from the residual plasmid DNA. So from the bacteria that the uh the mRNA was made from, we've got this DNA contamination. And, of course, we've looked at this in great detail with um Dr. David Speaker from Canada, for example, who did a lot of the original work and has published that finding. Very large amounts of DNA contamination in the mRNA vaccines that simply shouldn't be there, and we'll we know that that is not something that we that we want by any means.
[17:46]DNA integration may include the risk of tumorgenesis if insertion reduces the activity of a tumor suppressor or increases the activity of an oncogene. So, tumor suppressor genes, of course, prevent cancer. There are natural genes that prevent cancer. Oncogenes are genes which if stimulated can cause cancer. Now, you might wonder why we have genes in our genome that can cause cancer. Well, we don't, but we have genes that stimulate the development of us from when we were a single cell to when we were a baby ready to be born. We need a lot of um growth stimulating genes. And uh if these genes are stimulated in later life, they still cause growth, but this time, of course, we don't want growth and that growth becomes malignant. So, basically, if the DNA integration is uh is reducing the activity of a tumor suppressor gene, that can lead to more cancer. If it's increasing the activity of an oncogene, that can lead to more cancer. Two mechanisms there by which it can cause more cancers. Um, a few more if you're still interested, uh vaccine induced T-cell immunosuppression, impairing cancer surveillance. So the vaccine can suppress the T-cells and uh we learned from Professor Angas Dalgleish that these T-cells, especially the T uh cytotoxic cells, are very important for recognizing and killing cancer cells at an early stage.
[19:15]A big part of the reason that cancer becomes more common in later life is that T-cell activity goes down in later life, thereby predisposing us to cancer. Um, but if the vaccines are doing that directly, then that can predispose to cancer by reducing immuno surveillance. Interaction between the S2 subunit of the spike protein and the oncosuppressor proteins. So oncosuppressor proteins come from oncosuppressor genes, particularly p53 reduces cancer, BRCA1 and BRCA2 reduce cancer. And you probably BRCA is a breast cancer this was discovered the BRCA, the braca genes. So, if you've got a mutation in bracket gene one, you won't produce bracket gene protein. And because bracket gene one protein is an oncosuppressor gene, if you have less of that, then you've nothing to suppress the tumors and you get more breast cancer and ovarian cancer, prostate cancer probably. Um, so people have natural mutations in that get cancers young, but if there's interactions between this particular subunit of the spike protein and these proteins, then it's a very similar effect. We get reduced oncosuppressor proteins, therefore more onco because the onco is not suppressed and, of course, onco is cancer. Yep, the impairment of type I interferon signaling, which has all sorts of things. Increased transforming of uh growth beta, growth factor beta alpha production. Vaccine begins to accumulate rapidly, particularly in the bone marrow after injection. So this interferon on things, these are all things, these are all anti-cancer things that are interfered with, therefore making us more predisposed to cancer.
[21:05]And uh this will make us more predisposed to inflammation and subsequent cancers.
[22:19]Um, and we know that if you have more pro-inflammatory cytokines, you'll have more inflammation, and we know that inflammation predisposes to cancer. It all makes sense. I am afraid it all makes sense. We first learned about this years ago. Doctor, uh Professor Angas Dalgleish told us about it, leading oncologist that he's noting in some of his melanoma patients who've been stable for five, 10, 15, I think one for 20 years, after they had the injection that the melanomas are reactivated. So we've got new cancers appearing, as in this tragically young woman in the case study, and in people that have been managed for a long time, we're getting recurrence of cancers. Sadly, those two pieces of evidence support each other. This uh cytokine milieu activates the, I'm not going to go into this, but the STAT3 pathway, which promotes malignant T-cell proliferation, so malignant white blood cells, cancerous white blood cells. It increases the cancerous blood cells survival and resistance to apoptosis in T-cell lymphoma. So what's supposed to happen, apoptosis is um when a cell goes malignant, it's supposed to realize and kill itself. Apoptosis is cell suicide, but uh these malignant cells become more proliferative, there's more of them produced. They survive for longer and they don't commit suicide like they're supposed to. Therefore, they proliferate, causing what's called a T-cell lymphoma, which, of course, is a deadly, potentially deadly condition. Repeated vaccination exacerbation, over-expression and T-cell exhaustion, so the other way around the T-cells just get tired and don't work anymore. Impairing immune surveillance and enabling tumor growth. Because the cancer cells aren't killed by the T-cells. Repeated booster doses correlating with increased levels of the immunosuppressive subtype immunoglobulin G4. We've looked at this with Professor Clancey. We really have been lucky to talk to some of the real world leading authorities uh on this channel, hearing directly from the horse's mouth, as it were. And we know that these are are suppressive um immunoglobulins, the the IgG4s, and if you again if you suppress the immunity you suppress the uh the natural immuno surveillance of malignant cells. So we've got two things going on, we've got stimulation of of uh potential new malignant cells and we've got suppression of the normal cells. Therefore, the normal immune system is no longer able to combat the the cancers. Um, bad combination of things. Now, I have got a message. I've gone a bit I've gone on a bit longer than I meant to actually. So, I think I'll just post this video. Uh and then we'll have a message from Dr. Polykretis uh in the next video. Let's do that. For now, thank you for watching.
